These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3081375)

  • 41. Characteristics of ovarian follicles in spontaneous and stimulated cycles in which there was an endogenous luteinizing hormone surge.
    Templeton A; Messinis IE; Baird DT
    Fertil Steril; 1986 Dec; 46(6):1113-7. PubMed ID: 3096795
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gonadotropin, estrogen and progesterone response to long term gonadotropin-releasing hormone infusion at various stages of the menstrual cycle.
    Jewelewicz R; Dyrenfurth I; Ferin M; Bogumil J; Vande Wiele RL
    J Clin Endocrinol Metab; 1977 Oct; 45(4):662-7. PubMed ID: 334788
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum follicle-stimulating and luteinizing hormone and progesterone in single and multiple gestations following induction of ovulation.
    Fogel M; Rubin BL; Ossowski R
    Am J Obstet Gynecol; 1972 Mar; 112(5):629-39. PubMed ID: 5059593
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effects of gonadotrophin-releasing hormone agonist on follicular development in patients with polycystic ovary syndrome in an in-vitro fertilization and embryo transfer programme.
    Gersak K; Meden-Vrtovec H; Tomazevic T
    Hum Reprod; 1994 Sep; 9(9):1596-9. PubMed ID: 7836506
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
    Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA
    Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Peripheral and not central suppression of ovarian function during osmotic pump infusion of adrenocorticotropin-(1-24) for one menstrual cycle in the cynomolgus monkey and its partial compensation by a transitory elevation of sex hormone-binding globulin levels.
    Kowalski W; Chatterton RT
    Endocrinology; 1992 Jun; 130(6):3582-92. PubMed ID: 1597155
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pregnancy following induction of ovulation with pure FSH after suppression of endogenous gonadotropins with subcutaneous buserelin.
    Albert PJ; Schläfke J; Kaesemann H; Gille J
    Arch Gynecol Obstet; 1987; 241(1):53-6. PubMed ID: 3118825
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oral contraceptive pills and follicular fluid hormones in an in vitro fertilization program.
    Weisman Z; Dirnfeld M; Lissak A; Sorokin Y; Abramovici H
    Fertil Steril; 1989 Sep; 52(3):451-3. PubMed ID: 2506078
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ovarian hyperstimulation for successful in vitro fertilization and embryo transfer.
    Gronow MJ
    Acta Obstet Gynecol Scand Suppl; 1985; 131():1-80. PubMed ID: 3925706
    [No Abstract]   [Full Text] [Related]  

  • 50. Use of hMG and/or FSH for multiple follicle development.
    Rosenwaks Z; Muasher SJ; Acosta AA
    Clin Obstet Gynecol; 1986 Mar; 29(1):148-57. PubMed ID: 3082552
    [No Abstract]   [Full Text] [Related]  

  • 51. Differences in hormonal patterns during the first postabortion menstrual cycle after two techniques of termination of pregnancy.
    Blazar AS; Harlin J; Zaidi AA; Diczfalusy E
    Fertil Steril; 1980 May; 33(5):493-500. PubMed ID: 6768597
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ovarian follicular maturation in women. II. Reversal of estrogen inhibited ovarian folliculogenesis by human gonadotropin.
    Archer DF; Zeleznik AJ; Rockette HE
    Fertil Steril; 1988 Oct; 50(4):555-61. PubMed ID: 3139462
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Administration of an aromatase inhibitor during the late follicular phase of gonadotropin-treated cycles in rhesus monkeys: effects on follicle development, oocyte maturation, and subsequent luteal function.
    Zelinski-Wooten MB; Hess DL; Baughman WL; Molskness TA; Wolf DP; Stouffer RL
    J Clin Endocrinol Metab; 1993 Apr; 76(4):988-95. PubMed ID: 8473415
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Luteinizing hormone increases estradiol secretion but has no effect on progesterone concentrations in the late follicular phase of in vitro fertilization cycles in women treated with gonadotropin-releasing hormone agonist and follicle-stimulating hormone.
    Adonakis G; Deshpande N; Yates RW; Fleming R
    Fertil Steril; 1998 Mar; 69(3):450-3. PubMed ID: 9531875
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Luteinizing hormone bioactivity in human menopausal gonadotropin/human chorionic gonadotropin-induced cycles.
    Abuzeid MI; Yeoman R; Aksel S
    Fertil Steril; 1987 Feb; 47(2):238-43. PubMed ID: 3102284
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Altered follicular development in clomiphene citrate versus human menopausal gonadotropin-stimulated cycles for in vitro fertilization.
    Dlugi AM; Laufer N; Botero-Ruiz W; DeCherney AH; Polan ML; Haseltine FP; Mezer HC; Behrman HR
    Fertil Steril; 1985 Jan; 43(1):40-7. PubMed ID: 3155509
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Triggering of ovulation in human menopausal gonadotrophin-stimulated cycles: comparison between intravenously administered gonadotrophin-releasing hormone (100 and 500 micrograms), GnRH agonist (buserelin, 500 micrograms) and human chorionic gonadotrophin (10,000 IU).
    Gerris J; De Vits A; Joostens M; Van Royen E
    Hum Reprod; 1995 Jan; 10(1):56-62. PubMed ID: 7745071
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Revival of the natural cycles in in-vitro fertilization with the use of a new gonadotrophin-releasing hormone antagonist (Cetrorelix): a pilot study with minimal stimulation.
    Rongières-Bertrand C; Olivennes F; Righini C; Fanchin R; Taïeb J; Hamamah S; Bouchard P; Frydman R
    Hum Reprod; 1999 Mar; 14(3):683-8. PubMed ID: 10221695
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A randomized comparative study of purified follicle stimulating hormone and human menopausal gonadotropin after pituitary desensitization with Buserelin for superovulation and in vitro fertilization.
    Bentick B; Shaw RW; Iffland CA; Burford G; Bernard A
    Fertil Steril; 1988 Jul; 50(1):79-84. PubMed ID: 3133251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.